Equities

KORU Medical Systems Inc

KRMD:NAQ

KORU Medical Systems Inc

Actions
  • Price (USD)2.25
  • Today's Change0.08 / 3.69%
  • Shares traded316.33k
  • 1 Year change-45.91%
  • Beta0.5883
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. It is focused on home and specialty infusion solutions. The Company’s focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

  • Revenue in USD (TTM)28.52m
  • Net income in USD-13.74m
  • Incorporated2023
  • Employees82.00
  • Location
    KORU Medical Systems Inc100 Corporate DriveMAHWAH 07430United StatesUSA
  • Phone+1 (845) 469-2042
  • Fax+1 (845) 469-5518
  • Websitehttps://www.korumedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pro-Dex Inc48.24m5.00m65.34m146.0013.382.0710.811.351.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Alpha Pro Tech, Ltd.61.23m4.19m69.08m124.0016.681.1013.511.130.35430.35435.165.390.91691.7211.25493,814.506.2715.216.5216.0637.2840.236.8412.9312.83--0.000.00-1.215.6027.642.935.50--
Monogram Orthopaedics Inc365.00k-13.75m73.91m28.00------202.50-0.4621-0.46210.0123--0.0241----13,035.71-90.82-119.26-149.39-257.400.00---3,765.81-5,045.60----0.00-------0.3964---15.97--
Vivos Inc19.50k-2.89m80.68m10.00--59.22--4,137.54-0.0079-0.00790.000050.00350.0116--2.17---172.67-202.25-191.32-552.77-30.9710.79-14,844.92-11,969.07----0.00---46.58---17.19------
Vuzix Corp12.13m-50.15m85.44m94.00--1.06--7.04-0.7893-0.78930.19121.250.1111.463.10129,033.50-45.91-41.61-50.66-44.80-21.72-6.13-413.46-317.286.23--0.00--2.488.42-23.02--39.42--
Envoy Medical Inc316.00k-29.91m86.83m34.00------274.77-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
Vivani Medical Inc0.00-25.65m91.26m44.00--4.08-----0.5042-0.50420.000.40680.00----0.00-52.93-56.58-60.80-67.66-------2,868.72----0.00-------84.69--40.33--
Myomo Inc19.24m-8.15m100.56m101.00--10.66--5.23-0.2726-0.27260.62650.33131.563.788.99190,506.40-65.86-81.78-104.03-115.2768.5168.50-42.34-85.762.16--0.00--23.7051.0924.00--2.82--
KORU Medical Systems Inc28.52m-13.74m102.85m82.00--5.05--3.61-0.3012-0.30120.62540.44570.80572.397.50347,776.50-38.82-17.60-46.28-20.2958.5959.44-48.18-21.703.77--0.0351--2.2310.44-58.65--11.10--
Neuronetics Inc71.35m-30.19m106.56m203.00--3.02--1.49-1.06-1.062.491.180.61322.094.86351,468.00-25.95-28.02-33.60-34.7375.1375.73-42.31-51.044.33-5.280.6342--9.426.2218.76--18.57--
Fonar Corp102.42m12.16m107.43m561.009.180.65565.171.051.741.7414.6024.420.512420.351.44182,570.608.338.738.649.6045.6748.3316.2516.399.15--0.0055--1.083.89-24.71-15.058.48--
Xtant Medical Holdings Inc91.30m660.00k112.12m207.00--2.1829.241.23-0.0042-0.00420.7550.39451.191.325.78441,072.500.8636-10.381.15-14.6860.7561.080.7229-8.661.22-4.020.2997--57.504.81107.78--18.47--
TELA Bio Inc58.45m-46.66m114.15m227.00--6.01--1.95-2.06-2.062.560.77080.80131.477.15257,502.20-63.97-52.00-80.09-60.9568.6265.32-79.83-107.653.45-8.440.6821--41.1347.85-5.35---17.12--
Akso Health Group - ADR2.20m-17.07m124.67m12.00------56.60-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
Delcath Systems Inc2.07m-47.68m137.37m76.00--7.79--66.52-2.98-2.980.12730.69310.07310.23876.8027,171.05-168.85-116.57-377.02-243.2169.2571.02-2,308.86-1,235.372.06-26.530.3915---24.05-9.53-30.60---5.26--
Data as of May 01 2024. Currency figures normalised to KORU Medical Systems Inc's reporting currency: US Dollar USD

Institutional shareholders

51.09%Per cent of shares held by top holders
HolderShares% Held
Horton Capital Management LLCas of 31 Mar 20247.76m16.98%
First Light Asset Management LLCas of 31 Dec 20235.16m11.30%
Archon Capital Management LLCas of 31 Dec 20233.72m8.14%
The Vanguard Group, Inc.as of 31 Dec 20231.84m4.03%
BlackRock Fund Advisorsas of 31 Dec 20231.53m3.35%
272 Capital LPas of 31 Dec 2023824.53k1.80%
Geode Capital Management LLCas of 31 Dec 2023761.48k1.67%
Albion Management Group Ltd.as of 31 Mar 2024741.35k1.62%
Meros Investment Management L.P.as of 31 Dec 2023525.76k1.15%
SSgA Funds Management, Inc.as of 31 Dec 2023486.91k1.07%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.